Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.
about
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cellsEnhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth.
P2860
Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Antihormone induced compensato ...... pment of endocrine resistance.
@en
Antihormone induced compensato ...... pment of endocrine resistance.
@nl
type
label
Antihormone induced compensato ...... pment of endocrine resistance.
@en
Antihormone induced compensato ...... pment of endocrine resistance.
@nl
prefLabel
Antihormone induced compensato ...... pment of endocrine resistance.
@en
Antihormone induced compensato ...... pment of endocrine resistance.
@nl
P2093
P2860
P356
P1476
Antihormone induced compensato ...... pment of endocrine resistance.
@en
P2093
Carol M Dutkowski
Denise Barrow
Hayley E Francies
Iain R Hutcheson
Janice M Knowlden
Julia M W Gee
Lindy Goddard
Nicola J Jordan
Richard A McClelland
Robert I Nicholson
P2860
P356
10.1515/HMBCI.2011.009
P577
2011-03-01T00:00:00Z